​This report, part of the Roll Back Malaria Progress & Impact Series, provides an overview of mathematical modelling, explains its history in relation to epidemiology and malaria, and details its implications and uses for global and national malaria control and elimination planning. The report aims to expand the dialogue within the global malaria community—and among public health decision-makers in particular—on when and how mathematical modelling can help inform malaria control programs and policies.

Author: Chitnis N, Schapira A, Smith DL, Smith T, Hay SI, Steketee R

Publication date: November 2010

Region: Africa

Part of series: Roll Back Malaria Progress & Impact Series

This report provides an overview of Nicaragua's health system and diagnostic needs. It is supported by individual case studies on Chagas disease, dengue, and malaria in Nicaragua. These studies focus on several factors influencing the health care system in Nicaragua, including recent trends, regional and national control strategies, financing and partnerships, and the unmet clinical needs associated with each illness.

Author: Sequeira M, Espinoza H, Amador JJ, Domingo G, Quintanilla M, de los Santos T

Publication date: February 2011

Region: Latin America

This brochure outlines PATH's work in Ethiopia to improve health. We work side by side with Ministry of Health officials, nongovernmental organizations, multilateral agencies, and other development-sector partners to bring our extensive experience and expertise to bear on the country’s health challenges. Our alliances with hundreds of community collaborators provide an entry point for reaching families and communities to improve health and promote change from the ground up.

Publication date: December 2011

Region: Africa

The PATH Malaria Vaccine Initiative (MVI) is a vaccine development program of PATH. This fact sheet provides an overview of MVI's history, mission, vision, and work.

Publication date: November 2012

Region: Global

This issue of PATH Today describes PATH's multipronged approach to eliminating malaria in Africa and the development of semisynthetic artemisinin, a key ingredient in malaria treatment. It includes updates on PATH's work to prevent diarrhea in Cambodia and to diagnose cervical cancer. It also contains a profile of Dean Allen, CEO of McKinstry and PATH's board treasurer.

Publication date: May 2013

Region: Global

Part of series: PATH Today

This fact sheet describes PATH's work to improve malaria diagnosis, treatment, and referral practices in the private sector to contain drug-resistant parasites in Cambodia.

Publication date: January 2011

Region: Asia

Late-stage trials of an advanced malaria vaccine candidate—which, if approved, would become the world’s first malaria vaccine—are under way. This article, published in Health Affairs, recounts the pivotal roles played by collaborations of nonprofit organizations, pharmaceutical companies, private and public donors, and countries whose citizens would benefit most directly from a vaccine.

Author: Loucq C, Birkett A, Poland D, Botting C, Nunes J, Ethelston S

Publication date: June 2011

Region: Africa

This document is intended to start discussions around quantifying the need for safe injection equipment and the amount of infectious sharps waste produced by testing and treatment programs for diseases such as HIV/AIDS, tuberculosis, and malaria. The analysis was developed to support advocacy efforts to integrate injection safety as an essential element of all health care programs.

Publication date: June 2009

Region: Global

Part of the Technology Updates series, this fact sheet describes PATH's work to develop a rapid, easy-to-read, low-cost test for malaria.

Publication date: May 2009

Region: Global

Part of series: Technology Updates

This fact sheet summarizes PATH's work to curb emerging and epidemic diseases such as HIV/AIDS, tuberculosis, and malaria. Topic areas include advancing technologies to improve prevention, diagnosis, and treatment; strengthening health systems; encouraging healthy behaviors; and mobilizing and supporting our partners.

Publication date: September 2012

Region: Global

Part of series: PATH's areas of focus fact sheets

The third report of the Roll Back Malaria Progress & Impact Series analyzes the impact of malaria control scale-up on child mortality over the last decade in 34 malaria-endemic African countries. Using the Lives Saved Tool, this report demonstrates the dramatic progress made toward achieving the Millennium Development Goals related to malaria and child survival—and the potential consequences of decreasing our commitment to fighting the disease.

Author: Eisele T, Larsen D, Walker N, Steketee R, Cibulskis R

Publication date: September 2010

Region: Africa

Part of series: Roll Back Malaria Progress & Impact Series

This report details malaria research and development funding from 2004 to 2009, including how much funding went to each product area, who provided the funding, and how investments flowed from funders to recipients. The report assesses progress against the Global Malaria Action Plan funding goals to identify what is needed in the next decade.

Publication date: June 2011

Region: Global

This website about PATH’s Tanzania country program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2013

Region: Africa

Part of series: PATH's program websites

The second report in the Roll Back Malaria Progress & Impact Series benchmarks the remarkable progress and momentum that are building toward halting malaria in Africa.

Author: Johansson EW, Steketee R

Publication date: April 2010

Region: Africa

Part of series: Roll Back Malaria Progress & Impact Series

This website about PATH’s Zambia country program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2013

Region: Africa

Part of series: PATH's program websites